Argenx

Neuromuscular Disorders

Research activity centres on generalized myasthenia gravis, ocular myasthenia gravis, multifocal motor neuropathy, chronic inflammatory demyelinating polyneuropathy, amyotrophic lateral sclerosis, and congenital myasthenic syndromes, with additional interest in pediatric and adult forms of these conditions.

Myasthenia gravis
Chronic inflammatory demyelinating polyneuropathy
Amyotrophic lateral sclerosis

Trials also extend to AChR-antibody positive and seronegative disease subtypes, reflecting broad involvement across autoimmune neuromuscular weakness.

Autoimmune Thrombocytopenia

The sponsor funds studies in primary immune thrombocytopenia and chronic immune thrombocytopenia, including work that spans adult and adolescent populations.

Primary immune thrombocytopenia
Chronic immune thrombocytopenia
Immune-mediated platelet disorders

These programs focus on autoimmune platelet destruction and persistent bleeding risk associated with reduced platelet counts.

Connective Tissue and Systemic Autoimmune Disease

Clinical research includes primary Sjögren’s syndrome, systemic sclerosis, idiopathic inflammatory myopathy, dermatomyositis, and related myositis syndromes.

Primary Sjögren’s syndrome
Systemic sclerosis
Dermatomyositis

Additional activity covers active idiopathic inflammatory myopathy and broader systemic autoimmune manifestations affecting muscle, skin, and exocrine glands.

Studies address bullous pemphigoid and thyroid eye disease, with attention to immune-mediated skin blistering and orbital inflammation.

Bullous pemphigoid
Thyroid eye disease
Autoimmune skin disorders

These areas reflect interest in disorders driven by pathogenic autoantibodies and inflammatory tissue injury.

Transplantation and Renal Complications

Argenx also supports research in kidney transplantation, including antibody-mediated rejection and delayed graft function, alongside studies examining renal impairment and transplant-related immune complications.